Quoin Pharmaceuticals, Ltd.
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
DUNN GORDON officer: Chief Financial Officer
Ordinary Shares 122,221 $0.45 $54,999
Purchase
DUNN GORDON officer: Chief Financial Officer
Series F Warrants (right to buy) 122,221 $0.45 $54,999
Purchase
CARTER DENISE P. director, officer: Chief Operat..
Series G Warrants (right to buy) 555,556 $0.45 $250,000
Purchase
MYERS MICHAEL director, officer: Chief Execut..
Ordinary Shares 555,556 $0.45 $250,000
Purchase
MYERS MICHAEL director, officer: Chief Execut..
Series F Warrants (right to buy) 555,556 $0.45 $250,000
Purchase
MYERS MICHAEL director, officer: Chief Execut..
Series G Warrants (right to buy) 555,556 $0.45 $250,000
Purchase
CULVERWELL ANTHONY JAMES director
Series F Warrants (right to buy) 100,000 $0.45 $45,000
Purchase
CULVERWELL ANTHONY JAMES director
Series G Warrants (right to buy) 100,000 $0.45 $45,000
Purchase
CARTER DENISE P. director, officer: Chief Operat..
Ordinary Shares 555,556 $0.45 $250,000
Purchase
CARTER DENISE P. director, officer: Chief Operat..
Series F Warrants (right to buy) 555,556 $0.45 $250,000
Purchase
DUNN GORDON officer: Chief Financial Officer
Series G Warrants (right to buy) 122,221 $0.45 $54,999
Purchase
CULVERWELL ANTHONY JAMES director
Ordinary Shares 100,000 $0.45 $45,000
Sale
LANGER DENNIS director
Ordinary Shares 297 $0.73 $217

Showing 1 to 13 of 13 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.